These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 12570963)

  • 21. Relationship of Age With Stroke and Death in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: AMADEUS Trial.
    Senoo K; Lip GY
    Stroke; 2015 Nov; 46(11):3202-7. PubMed ID: 26463692
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Left atrial appendage occlusion debate revisited.
    Whitlock RP; Healey JS; Holmes DR
    Circulation; 2015 Feb; 131(8):756-61. PubMed ID: 25712058
    [No Abstract]   [Full Text] [Related]  

  • 23. Stroke prevention in atrial fibrillation.
    Waldo AL
    JAMA; 2003 Aug; 290(8):1093-5. PubMed ID: 12941684
    [No Abstract]   [Full Text] [Related]  

  • 24. Stroke in heart failure: atrial fibrillation revisited?
    Pullicino P; Homma S
    J Stroke Cerebrovasc Dis; 2010 Jan; 19(1):1-2. PubMed ID: 20123219
    [No Abstract]   [Full Text] [Related]  

  • 25. Rivaroxaban Versus Dabigatran or Warfarin in Real-World Studies of Stroke Prevention in Atrial Fibrillation: Systematic Review and Meta-Analysis.
    Bai Y; Deng H; Shantsila A; Lip GY
    Stroke; 2017 Apr; 48(4):970-976. PubMed ID: 28213573
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
    Mant JW
    Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
    [No Abstract]   [Full Text] [Related]  

  • 27. [GASTROINTESTINAL COMPLICATIONS OF ANTICOAGULANT THERAPY IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION].
    Novikova NA; Volovchenko AN; Oldakovsky VI
    Eksp Klin Gastroenterol; 2015; (6):57-63. PubMed ID: 26817106
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Atrial fibrillation, is warfarin the only option for stroke prevention?
    Khan M; Kamal AK
    J Pak Med Assoc; 2011 Mar; 61(3):301-2. PubMed ID: 21465955
    [No Abstract]   [Full Text] [Related]  

  • 29. Closure of Left Atrial Appendage to Prevent Stroke: Devices and Status.
    Safavi-Naeini P; Rasekh A
    Tex Heart Inst J; 2018 Jun; 45(3):172-174. PubMed ID: 30072856
    [No Abstract]   [Full Text] [Related]  

  • 30. Should surgical ablation for atrial fibrillation be performed in patients with a significantly enlarged left atrium?
    Ad N; Henry L; Hunt S; Holmes SD
    J Thorac Cardiovasc Surg; 2014 Jan; 147(1):236-41. PubMed ID: 24183909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strategies for stroke prevention in atrial fibrillation.
    Chung MK; Burkhardt JD; Klein AL
    Heart Rhythm; 2005 Jan; 2(1):103-6. PubMed ID: 15851275
    [No Abstract]   [Full Text] [Related]  

  • 32. Preventing stroke and systemic embolism in renal patients with atrial fibrillation: focus on anticoagulation.
    Ahmad Y; Lip GY
    Contrib Nephrol; 2013; 179():81-91. PubMed ID: 23652451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stratification with CHA2DS2-VASc score is better than CHADS2 score in reducing ischemic stroke risk in patients with atrial fibrillation.
    Pieri A; Lopes TO; Gabbai AA
    Int J Stroke; 2011 Oct; 6(5):466. PubMed ID: 21951414
    [No Abstract]   [Full Text] [Related]  

  • 34. Preventing stroke in patients with atrial fibrillation.
    Edds W; Newton W
    J Fam Pract; 2000 Jan; 49(1):8-9. PubMed ID: 10678330
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of anticoagulation around pacemaker and defibrillator surgery.
    Birnie DH; Healey JS; Essebag V
    Circulation; 2014 May; 129(20):2062-5. PubMed ID: 24842933
    [No Abstract]   [Full Text] [Related]  

  • 36. Is Apixaban (Eliquis) the "ideal" anticoagulant to replace warfarin for stroke prevention in atrial fibrillation?
    Strain J; Templeton K
    S D Med; 2013 Jan; 66(1):20-1. PubMed ID: 23342716
    [No Abstract]   [Full Text] [Related]  

  • 37. Efficacy and Safety of Apixaban Compared With Warfarin in Patients With Atrial Fibrillation and Peripheral Artery Disease: Insights From the ARISTOTLE Trial.
    Hu PT; Lopes RD; Stevens SR; Wallentin L; Thomas L; Alexander JH; Hanna M; Lewis BS; Verheugt FW; Granger CB; Jones WS
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28096100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Recent development of anticoagulation in stroke prevention for atrial fibrillation].
    Suzuki S; Yamashita T
    Nihon Rinsho; 2014 Jul; 72(7):1282-6. PubMed ID: 25163322
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newer anticoagulants as an alternate to warfarin in atrial fibrillation: a changing paradigm.
    Chaudhari D; Bhuriya R; Arora R
    Am J Ther; 2011 Jan; 18(1):e1-e11. PubMed ID: 20460986
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is warfarin still underused in patients with atrial fibrillation? A major threat to treatment benefit.
    Baysan O; Yokusoglu M; Bugan B
    Int J Cardiol; 2010 Oct; 144(3):439-40. PubMed ID: 19346015
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.